1-3 of 3
Axel Rüfer
Close
Sort by
Journal Articles

Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)

Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Heike Faeth, Renata Rosa Pereira, Anna Wieland, Jan Dirks, Falk Nimmerjahn, Thomas Kuehne
Journal: Blood
Blood (2021) 138 (Supplement 1): 3149.
https://doi.org/10.1182/blood-2021-146648
Published: 2021
Journal Articles

Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma

Clinical Trials & Observations
Christoph Driessen, Rouven Müller, Urban Novak, Nathan Cantoni, Daniel Betticher, Nicolas Mach, Axel Rüfer, Ulrich Mey, Panagiotis Samaras, Karin Ribi, Lenka Besse, Andrej Besse, Catherine Berset, Stephanie Rondeau, Hanne Hawle, Felicitas Hitz, Thomas Pabst, Thilo Zander
Journal: Blood
Blood (2018) 132 (19): 2097–2100.
https://doi.org/10.1182/blood-2018-05-851170
Published: 2018
Includes: Supplemental data
Journal Articles

Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2 -Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

Beatrice Drexler, MD, Jakob Passweg, MD, Martin Bigler, Alexandre PA Theocharides, MD, Nathan Cantoni, MD, Peter Keller, MD, Georg Stuessi, MD, Axel Rüfer, MD, Rudolf A. Benz, MD, Geneviève Favre, MD, Alexandar Tzankov, MD, Pontus Lundberg, PhD, Andrea Fuhrer, PhD, Christine Biaggi, Markus G Manz, MD, Mario Bargetzi, MD, Simon Mendez-Ferrer, PhD, Radek C. Skoda, MD
Journal: Blood
Blood (2016) 128 (22): 3108.
https://doi.org/10.1182/blood.V128.22.3108.3108
Published: 2016